






1125-11 Percutsneous Coronary Intervention of Complex 
Lesions la Associated With Increased In-Hoapitsl and 
One-Year Adverse Event Rates: Results From the NHLBI 
Dynamic Registry 
Robert L. Wifenskv. Janet Johnston, Faith Seizer, Bruce D. Klugherz, Warren K. Laskey, 
Peter Block, Howard Cohen, Katherine Detre, David O. Williams, The Hospital of the 
University of Pennsylvnaia, Philadelphia, Pennsylvania, The University of Pittsburgh, 
Pittsburgh, Pennsylvania. 
Background: Advances in coronary intervention (PCI) have reduced complications but 
expanded indications to include more complex lesions. Methods. We assessed clinical 
event rates among pts undergoing PCI for complex lesions between 7/97-2/98 and 2/99- 
6/99. A complex lesion was defined as containing thrombus (Thr) or calcium (Ca), or in a 
bifurcation (Bif) or ostial (Os) location. Results. Of 4430 total patients, 2582 were treated 
for complex lesions (58.3%); they were older and more likely to present with an acute 
coronary syndrome. PCJ of a complex lesion was more likely to cause dissection, distal 
embolization, side branch occlusion or reduced blood flow, resulting in lesser success 
(91.9% vs 94.0%, p<0.05) and increased in-hospital and 1-yr event rates (Table). After 
adjusting for clinical, demographic and angiographic haracteristics pts with Thr had a 
greater risk of in-hospital death (D)/MI (Odds ratio [OR] =1.94; 95% CI = 1.32-2.83). Ca 
(OR 1.38, 95% C1=1.03-1.85) or Bif lesions (OR=1.48 95% C1=1.03-2.12) were indepen- 
dently associated with in-hospital D/MI/CABG. At 1-yr Bif lesions were independently 
associated with increased D/MI (RR = 1.31; 95% CI = 1.03-1.69) and MACE (RR = 1.33; 
95% CI = 1.13-1.57). Conclusions: PCI of complex lesions was associated with 
increased in-hospital and 1-yr adverse events. The increased in-hospital event rate was 
noted independently for thrombotic, bifurcation and calcified lesions. Bifurcation tesions 
were associated with worse long-term event rates. 
ABSTRACTS - ACClS2002 (Angiography & Interventional Cardiology) JACC March 6, 2002 
In-hospital One-Year 
Complex Death+ Death/Ml+ Death/MI/CABG+ Death+ Death/Ml* MACE+ 
Lesion? 
Yes 2.1% 5.4% 6.8% 6.2% 11 .9% 27.1% 
No 0.7% 2.3% 2.9% 3.8% 7.5% 22.7% 
*p<0.01 +p<0.001 
1125-12 Reduced Need for  Repeat Reveacularization Following 
Psrcutaneoua Coronary Intervention: A Report From 
the 1997-1999 NHLBI Dynamic Registry 
Janet M. Johnston, Tulay Koru-Sengul, Warren K. Leskey, Howard A. Cohen, Dynamic 
Registry Investigators, University of Pittsburgh, Pittsburgh, Pennsylvania. 
BACKGROUND: The NHLBI Dynamic Registry was established in 1997 to identify 
changes over time in the practice of percutaneous coronary intervention (PCI). This 
report focuses on patient outcomes during the year following PCI. 
METHODS: The design of the Dynamic Registry includes three enrollment waves of 
approximately 2000 patients each, separated by 18 month intervals. Wave 1 (July 1997 - 
February 1998) included 15 sites and Wave 2 (February - June 1999) included 16 sites. 
Patients were contacted by phone one year after the index PCI and clinical data including 
dates of major cardiac events were recorded. One year event rates were calculated 
using the Kaplan-Meier method and compared with the log rank'test. Cox regression was 
used to calculate adjusted risk ratios, 
RESULTS: One year event rates for death, myocardial infarction (MI), and coronary 
artery bypass grafting (CABG) were similar between the two waves. However, the one 
year repeat PCI rate decreased by approximately 20% from Wave 1 to Wave 2. This dif- 
ference remained after adjusting for differences in patient risk factors and lesion charac- 
teristics (adjusted RR = 0.80, 95% CI = 0.67 - 0.96). Increased use of stents (Wave 1 : 
67%; Wave 2: 79%;p<0.001) and cardiac medication (see table) may have an effect on 
the need for repeat PCI. 
CONCLUSIONS: One year event rates for death, MI, and CABG following PCI were sim- 
ilar between the two waves; however, the rate for repeat PCI declined. Changes in treat- 
ment strategies may be responsible for some of this decline. 
Wave 1 (N=2524) Wave 2 (N=1904) p-value 
One Year Events # Events (%) # Events (%) 
Death 111 (5.1) 95 (5.4) 0.668 
MI 125 (5.5) 107 (5.9) 0.525. 
CABG 156 (7.3) 108 (6.2) 0.182 
Repeat PCI 303 (14.7) 206 (12.1) 0.015 
Death/MI 220 (9.8) 187 (10.4) 0.495 
Death/MI/CABG 352 (15.8) 274 (15.2) 0.682 
Repeat PCI/CABG 425 (20.3) 288 (16.8) 0.004 
Cardiac Medication 
GP ltb/llla 24% 32% <0.001 
ACE Inhibitors 30% 37% <0.001 
Beta Blockers 65% 70% <0.001 
Statins 46% 62% <0.001 
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1126-13 Should Follow-Up Anglography Be Routine in 
Aaymptomatic Patients After Stsntlng of Unprotected 
Left Main Coronary Stenoala? 
Samin K. Sharma. Annapooma S. Kini, Cristina A. Mitre, Michael Kim, Mazullah Kamran, 
Jonathan D. Marmur, The Mount Sinai Medical Center, New York, New York. 
Background: Selected patients with unprotected left main coronary artery (ULMCA) 
stanosis can safely undergo stenting. Clinical restenosis after stenttng of ULMCA occurs 
in 8-15%. Earlier studies predominantly utilizing non-stent devices revealed =10% inci- 
dence of death at follow-up, perhaps due to rapidly progressive restenosis. This led to 
recommending routine angiography at 3-4 months after ULMCA intervention. However, 
its practical utility after ULMCA stanting is controversial. We present complete one-year 
follow-up of first 100 consecutive high-risk cases of ULMCA stenting deemed unsuitable 
for CABG. 
Methods: Baseline: mean age 82~-6 yrs, female 42%, mean LVEF 31:t:14%, GP inhibi- 
tore in 76%, and elective IABP in 34%. Stanosis location: ostium in 25%, body/distal in 
60%, and bifurcation in 15%. All patients underwent stenting, 89% after rotablation. 
Results: Procedure was successful in all patients without any major in-hospital compli- 
cations. Vascular complications occurred in 3%. Mean reference vessel diameter was 
3.81!-0.81 mm, MLD pre-procedure 1.12¢0.36 mm and post-procedure 3.67:L-0.52 mm. 
CK-MB elevation occurred in 21%, with >5x normal in 4%. All patients were discharged 
alive at a mean duration of 6t-5 days. At one-year follow-up there have been 14 deaths: 7 
cardiac (4 CHF, 1 MI, 1 arrhythmia, 1 stent thrombosis), 7 non-cardiac (3 CVA, 2 pneu- 
monia, 1 hyperkaliemia, 1 neoplasm). A total of 12 patients (12%) required repeat inter- 
vention for recurrence of angina, heart failure, or positive non-invasive testing. On 
multivariate analysis, bifurcation lesion intervention (OR 4.2; 95% CI 2.2-6.8) and diabe- 
tes (OR 2.4; 95% CI 1.8-3.2) were independent predictors of restenosis. No patients 
underwent CABG or had sudden death at follow-up. Protocol mandated angiography was 
done in 22 asymptomatic patients and none had >70% stenosis of LMCA. 
Conclusion: Present prospective careful observation suggests that ULMCA in-stent res- 
tenosis always manifests clinically. Extremely low incidence of sudden death at follow-up 
may obviate the need of routine follow-up angiography in these high-risk ULMCA 
patients. Whether this observation can be generalized to all ULMCA patients needs to be 
determined. 
1126-14 Frequency and Causes of Early Hospital Reedmlesion 
for Cheat Pain After Contemporary Coronary Stent 
Implantation 
Dusa n Knezevic, Jeffrey Moses, Zoran Lasic, Yen Li, Roberts Maida, Vledimir Ilic, David 
Bolon, Maja Zaric, Asu Rustemli, All Aboufares, Nell Coplan, George Dangas, Isssm 
Mousse, Lenox Hill Heart & Vascular Institute, New York, New York, Cardiovascular 
Research Fondation, New York, New York. 
Background: Stents greatly improved the safety of percutaneous coronae.,' intervention 
(PCI) and diminished eady complications. However the frequency end causes of early 
hospital readmission for chest pain following successful contemporary coronary stenting 
have not been well described. 
Methods end results: This study consisted of 1782 patients who had successful stent 
implantation in Lenox Hill Hospital and underwent a 30-day follow up. Of this population, 
71 patients (4.2%) were readmitted ue to chest pain. This group, compared to patients 
who were not readmltted, had a higher prevalence of cigarette smoking (34% vs.18%, 
p<0.001) and a lower prevalence of hypertension (61% vs. 72%, p<0.05). Only 10 
patients (14%) had ischemic ECG changes. Repeat target vessel revasculadzation was 
necessary in 13 patients (0.7%). This was due to stant thrombosis in two patients (0.1%) 
and to residual dissections or suboptimal results in 11 patients (0.6%). 
Conclueion: In this era of coronary stent implantation, a minority of patients is readmlt- 
ted due to chest pain after successful stenting. Further, repeat revasculadzation is 
required in only a small percentage of patients (0.7%). Therefore, more stringent cdtada, 
such as the presence of ischemic ECG changes or positive cardiac markers, should be 
applied prior to repeat angiography in these patients. 
1126-15 Long-Term Clinical Follow-Up After Unprotected Left 
Main Coronary Artery Stenting: Predictors of Mortality 
Marco Boccalatte. Paulino Souse, Alexander Black, Rossefla Gottilta, Bruno Farah, Jean 
Fajadet, Jean Paul Bounhoure, Jean Marco, Clinique Pasteur, Toulouse, France. 
Background: Unprotected left main coronary artery (LMCA) stenting has been proposed 
as an alternative to coronary artery bypass surgery (CABG) in selected patients. How- 
ever, experience is limited and further information regarding initial and long term follow- 
up is required. Methods:We report acute and follow up data (764¢-650 days) of 179 con- 
secutive pts that underwent unprotected LMCA stenting. Results: Procedure was suc- 
cessfully achieved in all pts. In-hospital MACE were 8.3%, mortality was 3.9%, non fatal 
MI 3.9%, TLR 0.5%. By Kaplan Meier analysis (KMA) 3 years survival is 77.7+ 0.49 % 
(mean±BEE) and freedom from Death, MI and TLR is 67.2 t"0.43%. Univariata predictors 
of death are: LVEF(59±14 VS 48¢15 %; p<0.0001), Stent length(14 ±5VS16±4 ram; 
p=0.02), Final Stent diam.(4±0.5 VS 3.8±0.4 ram; p= 0.03), Number of lesion treated (>2; 
p=0.03), Poor distal run off (p=0.003). By multivariate logistic regression LVEF [p< 
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the 2 major predictors of death. After reclassification of patients into High Risk and Low 
Risk categories according to the presence of well established deleterious factors for 
CABG (LVEF< 35%, age >75y, poor run off, renal faiture, and obstructive lung disease) 
we estimated survival by KMA. 
Survival according to Risk 
'1¢1. 
% 
Hll k Risk 
-,S 5,0 ,S 4,0 tp| 
Years 
2,0 2p5 3,0 
Conclusions: coronary stenting can be an alternative to CABG in low risk patients, with 
satisfactory 3 years outcome. In high risk patients for CABG this technique is feasible but 
the long term prognosis remains poor. 
1126-16 Primary Stenting With Abciximab in Acute Myocardial 
Infarction Complicated by Cardiogenic Shock (the 
ADMIRAL Trial) 
Gilles MontalQscot. Paul Barragan, Olivier Wittenberg, Simon Elhadad, Thierry Lef(bvra, 
Christophe Loubeyre, Antoine Lafont, Michel Zupan, Franck Paganelli, Philippe Pinton, 
Piti~ Salp{~tdbre Hospital, Paris, France. 
Patients with acute myocardial infarction (AMI) in oardiogeeic shock are at high-risk of 
mortality. In the randomized double blind ADMIRAL study, 300 patients undergoing pri- 
mary stenting for AMI were allocated to either abciximab or placebo. Twenty five patients 
(8.3 percent) amongst them presented a cardiogenic shock (CS) within the first 24 hours: 
7.3 percent in the abciximab group and 9.3 percent in the placebo group (P=0.55). The 
shock patients had more frequent dyslipidemia (P=0.01), prior myocardial infarction 
(P=0.02), prior PTCA (P=O.03) and diabetes (P=0.03) than non-shock patients. They 
were also more frequently male (P=O.05). The mortality rate was significantly higher in 
CS patients than in non-cardiogenic shock patients at 30 days (16 percent vs. 4 percent, 
respectively, P=O.O08) and at 6 months (16 percent vs. 4.4 percent, P=O.01). The rate of 
TIMI grade 2 or 3 flow was lower in CS patients compared to the others, on admission 
(8.3 percent vs. 19.3 percent, P=0.34) and at 24 hours (83.3 percent vs. 94.8 percent, 
P=0.23). The 24-hour re-occlusion rate was also higher (16.7 percent vs. 6.5 percent, 
respectively P=0.34). In CS patients, the rate of TIMI grade 2 or 3 flow was slightly higher 
with abciximab compared to placebo (14.3 percent vs. 0.0 percent, P=0.34) as well as at 
24 hours (100.0 percent va. 83.3 percent, P=0.34); the 24-hour re-occlusion rate was 
lower with abciximab (0.0 percent vs. 33.3 percent, P=0.21). At both 30 days and 6 
months, in CS patients, the primary endpoint including (death, myocardial infarction and 
urgent target vessel revascularization) tended to be lower with abciximab (9.1 percent 
versus 28.6 percent, P=0.23), Death was reduced by 57 percent with abciximab (9.1 per- 
cent vs. 21.4 percent, NS) at both 30 days and at 6 months. Considering the small sam- 
ple size, these results must be interpreted cautiously. However shock patients are 
usually excluded from randomized trials and little information is available for this popula- 
tion. Primary stenting with abciximab in AMI complicated by cardiogenic shock appears 
to provide similar benefit as in the rest of the population of this trial. These results would 
need further confirmation in a specific trial. 
1126-17 Totally Occluded In-Stent Restenotic Lesions Treated 
With Intracoronary Radiation: Six-Month Clinical and 
Anglographic Follow-Up 
Andrew E. A!ani, Edouard Cheneau, Dong-Hun Cha, Rosanna Chart, Hongsheng Wu, 
Hamid Yazdi, Daniel Canos, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, 
Joseph Lindsay, Ron Waksman, Washington Hospital Center, Washington, Dist. of 
Columbia. 
Background: Conventional PTCA of totally occluded (TO) coronary arteries with in-stent 
restenosis (ISR) is associated with higher rates of restenosis and reocclusion. The pur- 
pose of this study was to evaluate the effectiveness of intracoronary radiation therapy 
(IRT) in patients (pts) with TO of ISR lesions. Methods: Out of 669 patients who were 
enrolled into the WRIST studies (Washington Radiation for In-Stant Restenosis Trial) 
treated with a 7 emitter (Ir-192) and had 6-month clinical follow-up, 82 pts (12%) pre- 
sented at entry with TO of the target lesion. Seventy-nine of these patients (94%) under- 
went successful intervention using balloon, laser angioplasty, or additional stents (39%) 
to obtain an adequate angiographic result (<30% diameter stenosis). Results: Angio- 
graphic and clinical outcomes comparing pts with TO versus non-occlusive lesions were 
similar except for higher rates of late total occlusion (LTO) in the TO group (Table). Con- 
clusions: Total occlusion of ISR lesions at entry in the WRIST studies is not infrequent 
and has a successful recanalization rate with conventional percutaneous coronary inter- 
vention. Intrecoronary 7 radiation therapy for totally occluded ISR is feasible, safe and 
associated with similar outcomes to non-occlusive ISR. 
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Total Occlusion Non-Total Occlusion P value 
(N=82) (N=587) 
Angiographic Binary Restenosis, % 31 
Death, % 4 
Q-wave MI, % 3 








TVR, % 24 
Late Total Occlusion, % 12 
MACE, % 25 
1126-18 Acute Coronary Syndrome Is a Common Clinical 
Presentation of In-Stent Restenosis 
Darren Waiters. Scott Harding, Craig Walsh, Phillip Wong, Eugene Pomerantsev, Ik- 
kyung Jang, Massachusetts General Hospital, Boston, Massachusetts. 
Background; Coronary stents have been the major advancement in percutaneous coro- 
nary intervention (PCt) in the last decade and are used in 60 - 80% of the patients. How- 
ever, in-stent restenosis continues to be a problem, occurring in 20 - 30% of cases. The 
clinical presentation of patients who develop restenosis following stenting has not been 
well characterized. In this study we compared the clinical presentation of in-stant rest- 
enosis with that of PCI without stenting. 
Methods; Of 742 patients who underwent PCI and had repeat catheterization between 
10/1/97 and 6/30/00, 262 consecutive patients with recurrent iechemia and restenosis 
were identified: 191 patients with stenting (Group A) and 71 without stenting (Group B). 
Patients who underwent interventions in bypass grafts and those who developed eady 
acute stent thrombosis were excluded from the study 
Results; Recurrent clinical ischemia occurred at e mean of 5.5 months for Group A and 
6.4 months for Group B (p=0.24). Rest aegina (Braunwald Class II and III) was more fre- 
quent in Group A compared to Group B (47 vs 23%, p<0.05). Acute coronary syndromes, 
the combination of rest angina and acute myocardial infarction, were also more frequent 
in Group A (67 vs 46%, p<0.05). Patients in Group A were more likely to have anglo- 
graphically visible thrombus compared with those in Group B (9 vs 0%, p<0.05). 
Conclusions: The acute coronary syndromes are a common clinical presentation of rest- 
enosis in patients undergoing repeat angiography and occur more frequently in patients 
with in-steet restenosis compared to those with balloon angioplasty restenosis. 
1126-19 One-Year Outcomes of Unprotected and Protected Left 
Main Stenting in the Current Era 
Michael P. Kellev, Bruce D. Klugherz, Sayed M. Hashemi, Nicolas F. Meneveau, Janet M. 
Johnston, William H. Matthai, Jr., Vidya S. Banks, Howard C. Herrmann, John W. 
Hirshfeld, Jr., Daniel M. Kolansky, Phillip A. Horwitz, Francois Schiele, Jean-Pierre L. 
Bassand, Robert L. Wilensky, University of Pennsylvania Health System, Philadelphia, 
Pennsylvania, Cardiology Section, Hopital Jean Minjoz, Besancon, France. 
Backoround: Although coronary artery bypass surgery is the accepted treatment for left 
main coronary artery (LMCA) disease, improved coronary interventional techniques may 
facilitate a percutaneous approach. Data regarding patient outcomes following left main 
stenting remain limited. 
Methods: We retrospectively reviewed outcomes among 135 consecutive patients who 
underwent protected (left coronary artery grafted) or unprotected LMCA stenting and for 
whom one-year follow-up was available. Death, myocardial infarction (MI), target-lesion 
revascularization (TLR), and the combined major adverse clinical event (MACE) rates 
were computed. Demographic and procedural variables were tested in univariate and 
multivariate prediction models. 
Results: Mean age was 68 _+ 10 years and mean ejection fraction 48 + 10%. Ninety-four 
patients (70%) underwent protected and 41 patients (30%) underwent unprotected 
LMCA steering. Cardiogenic shock was present in 6% of patients. Glycoprotein 2B/3A 
receptor antagonists were used in 56 patients (43%). Clinical follow-up was obtained in 
95% of patients. Survival at one year was 88% for all patients (protected 95% and unpro- 
tected 71%), TLR 21%, and MACE 34%. For the 8 patients with cardiogenic shock, one- 
year survival was 50%. In a multivariate analysis, independent predictors of mortality 
included unprotected LMCA stent (odds ratio [OR] 8.7, 2.2-34.6, p=0.002) and cardio- 
ganic shock (OR 6.0, 1.03-34.9, p=0.05). Congestive heart failure was a univariate pre- 
dictor of survival (OR 3.3, 1.1-9.6, p=0.03). No univadate predictors of TLR were 
identified. 
Conclusion: In the setting of protected LMCA disease, percutaneous intervention has 
an acceptable one-year survival. Survival is reduced following unprotected LMCA stent- 
ing in this selected population of poor surgical candidates. In contrast to previous out- 
comes analyses of patients undergoing coronary stenting, diabetes is not e predictor of 
left main TLR or MACE. Target-lesion revascularization for left main stents appears simi- 
lar to stenting of other large corenaPJ arteries. 
